Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
PET Clinics|May 10, 2016
The Role of PET/CT in Advanced Malignant MelanomaImene Zerizer, Brian Ng Cheng Hin, Wing Yan Mok, et al.Clinical Nuclear Medicine|September 15, 2010
Occult squamous cell carcinoma of the uvula detected by F-18 FDG PET/CT in a case of carcinoma of unknown primary in the head and neckShahenda Salem, Neva H Patel, Tara Barwick, et al.Clinical Nuclear Medicine|July 9, 2021
Assessment of Apparent Diffusion Coefficients and SUVs as Predicators of Histological Differentiation in Anal Squamous Cell CarcinomaArman Parsai, Imene Zerizer, Hikmat Jan, et al.Molecular Imaging and Biology|April 9, 2010
The labeled-leukocyte scan in the study of abdominal abscessesMauro Liberatore, Enrico Calandri, Gabriele Ciccariello, et al.Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.Nuclear Medicine Communications|April 4, 2014
The value of combined assessment of vertebral fractures with 99mTc MDP scintigraphy and MRI in selecting and planning percutaneous vertebroplastyDerfel ap Dafydd, Shahenda Salem, Imene Zerizer, et al.Annals of Hematology|November 29, 2019
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trialAndrea Kühnl, Clare Peckitt, Bijal Patel, et al.The Lancet. Haematology|April 29, 2018
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trialMary Gleeson, Clare Peckitt, Ye Mong To, et al.Pageof 2